Xiaolong Li

No. 301 Yan Chang Zhong Road
Shanghai, 200072, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

LIFUS-driven engineered bacteria reprogram immunosuppressive niches via mechano-NOTCH signaling.

LIFUS-driven engineered bacteria reprogram immunosuppressive niches via mechano-NOTCH signaling.

Journal: Cell reports. Medicine
Published: September 03, 2025

Asian consensus statement of experts on thermal ablation for secondary hyperparathyroidism in chronic kidney disease.

Asian consensus statement of experts on thermal ablation for secondary hyperparathyroidism in chronic kidney disease.

Journal: International journal of surgery (London, England)
Published: January 14, 2025

Safety of radiofrequency ablation in patients with hyperparathyroidism: a 10-year real-world multicenter experience.

Safety of radiofrequency ablation in patients with hyperparathyroidism: a 10-year real-world multicenter experience.

Journal: European radiology
Published: December 28, 2024

Low-intensity focused ultrasound-activated piezoelectric gel bandage for diabetic wound repair and neuropathic pain relief.

Low-intensity focused ultrasound-activated piezoelectric gel bandage for diabetic wound repair and neuropathic pain relief.

Journal: Nature communications
Published: December 12, 2024

US-guided Percutaneous Radiofrequency Ablation for Secondary Hyperparathyroidism: Long-term Outcomes and Prognostic Factors.

US-guided Percutaneous Radiofrequency Ablation for Secondary Hyperparathyroidism: Long-term Outcomes and Prognostic Factors.

Journal: Radiology
Published: April 16, 2024

Epigenetics disruptions enabled by porphyrin-derived metal-organic frameworks disarm resistances to sonocatalytic ROS anti-tumor actions.

Epigenetics disruptions enabled by porphyrin-derived metal-organic frameworks disarm resistances to sonocatalytic ROS anti-tumor actions.

Journal: Fundamental research
Published: April 15, 2022

Abundance and Metabolism Disruptions of Intratumoral Microbiota by Chemical and Physical Actions Unfreeze Tumor Treatment Resistance.

Abundance and Metabolism Disruptions of Intratumoral Microbiota by Chemical and Physical Actions Unfreeze Tumor Treatment Resistance.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 30, 2021

Nanoparticle-enhanced radiotherapy synergizes with PD-L1 blockade to limit post-surgical cancer recurrence and metastasis.

Nanoparticle-enhanced radiotherapy synergizes with PD-L1 blockade to limit post-surgical cancer recurrence and metastasis.

Journal: Nature communications
Published: November 19, 2021

Syndecan-2, negatively regulated by miR-20b-5p, contributes to 5-fluorouracil resistance of colorectal cancer cells via the JNK/ERK signaling pathway.

Syndecan-2, negatively regulated by miR-20b-5p, contributes to 5-fluorouracil resistance of colorectal cancer cells via the JNK/ERK signaling pathway.

Journal: Acta biochimica et biophysica Sinica
Published: April 13, 2021

Biodegradable and Excretable 2D W1.33 C i-MXene with Vacancy Ordering for Theory-Oriented Cancer Nanotheranostics in Near-Infrared Biowindow.

Biodegradable and Excretable 2D W1.33 C i-MXene with Vacancy Ordering for Theory-Oriented Cancer Nanotheranostics in Near-Infrared Biowindow.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 15, 2021

Should transarterial chemoembolization be given before or after intensity-modulated radiotherapy to treat patients with hepatocellular carcinoma with portal vein tumor thrombus? a propensity score matching study.

Should transarterial chemoembolization be given before or after intensity-modulated radiotherapy to treat patients with hepatocellular carcinoma with portal vein tumor thrombus? a propensity score matching study.

Journal: Oncotarget
Published: June 01, 2017

Computational dissection of allosteric inhibition of the SH2 domain of Bcr-Abl kinase by the monobody inhibitor AS25.

Computational dissection of allosteric inhibition of the SH2 domain of Bcr-Abl kinase by the monobody inhibitor AS25.

Journal: Journal of molecular modeling
Published: December 29, 2016
Showing 1-12 of 12

Last Updated: 09/26/2026